Press R.R., Ploeger B.A., Hartigh J.d, Straaten T.v.d., van Pelt H., Danhof M., Fijter H.d. and Guchelaar H.J., Explaining variability in ciclosporin exposure in adult kidney transplant recipients, Eur J Clin Pharmacol., 66(6): 579-590. Epub 2010 Mar 2031., 2010. [Link to publication]
Press R.R., Rossum H.H. v., Ploeger B.A., Hartigh J.d., Pelt J.v., Guchelaar H.J., Fijter J.W.d. and Danhof M., Is Calcineurin activity useful as a biomarker to optimize cyclosporine a therapy in renal transplant recipients? PAGE.(2009).[Link to publication]
Muller A.E., Oostvogel P.M., Jongh J.d., Mouton J.W., Steegers E.A., Dorr P.J., Danhof M. and Voskuyl R.A., Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera, Antimicrob Agents Chemother, 53(4): 1574-1580, 2009. [Link to publication]
Press R.R., Ploeger B.A., Hartigh J. d, Straaten T.v.d., Pelt J.v., Danhof M., Fijter J.W.d and Guchelaar H.J., Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients, Ther Drug Monit., 31(2): 187-197., 2009. [Link to publication]
Press R.R., Ploeger B.A., Hartigh J.d., Straaten R.J.H.M.v.d., Pelt J.v., Danhof M., Fijter J.W.d. and Guchelaar H.J., Dose Prediction of Tacrolimus in de novo Kidney Transplant Patients with Population Pharmacokinetic Modelling Including Genetic Polymorphisms. PAGE.(2007). [Link to publication]
- « Previous
- 1
- 2